Nathan Clark

Riverain Technologies

Riverain ClearRead solutions significantly improve a clinician's ability to accurately and efficiently detect disease in thoracic (lung) CT and XR images and more successfully address the challenges of early detection of lung disease. Powered by machine learning and advanced modeling, the patented, FDA-cleared ClearRead software tools are deployed in the clinic or the cloud and are powered by the most advanced AI methods available to the medical imaging market. While the benefit for patients can be life changing, the advantages for radiologists are equally substantial. Battling growing workloads and less time, ClearRead solutions allow clinicians to complete more reads faster – saving valuable time without sacrificing performance.